Cuestionario CAVICAVENMI: calidad de vida en pacientes con cáncer de vejiga no músculo invasivo

Pedraza, Irache Abáigar; Garrigós, Julián Megías; Payá, José Sánchez; Calvo Simal, Sara.
urol. colomb. (Bogotá. En línea) ; 28(2): 161-168, 2019. tab, graf
Artículo en Español | LILACS, COLNAL | ID: biblio-1402342

Documentos relacionados

  1. Contemporary outcomes of bladder carcinoma in situ treated with an adequate bacille Calmette-Guérin immunotherapy.
  2. Clinical practice of UroVysion® urine test in patients with bladder carcinoma in situ treated with intravesical Bacillus Calmette-Guerin.
  3. Complete Remission of BCG-Refractory High-grade Bladder CIS with Pharmacologic Ascorbate and Mistletoe.
  4. Changes in cervical dysplasia, carcinoma in situ, and cervical cancer after expanding the National Cancer Screening Program to younger women in Korea.
  5. Active surveillance for non-muscle-invasive bladder cancer: fallacy or opportunity?
  6. Using machine learning to preoperatively stratify prognosis among patients with gallbladder cancer: a multi-institutional analysis.
  7. Impact of carcinoma in situ on the outcome of intravesical Bacillus Calmette-Guérin therapy for non-muscle-invasive bladder cancer: a comparative analysis of large real-world data.
  8. UBC®Rapid Is Sensitive in Detecting High-Grade Bladder Urothelial Carcinoma and Carcinoma in situ in Asian Population.
  9. The bladder epicheck test and cytology in the follow-up of patients with non-muscle-invasive high grade bladder carcinoma.
  10. Contribution of narrow band imaging in delineation of laryngopharyngeal superficial cancer spread: a prospective study.